{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:39:35Z","timestamp":1793090375392,"version":"4.5.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"DOI":"10.1038\/s41579-026-01352-5","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:19:01Z","timestamp":1787822341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phage therapy: from basic biology to clinical application"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3341-6922","authenticated-orcid":false,"given":"Holly A.","family":"Sinclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4163-511X","authenticated-orcid":false,"given":"Ruby C. Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6949-1755","authenticated-orcid":false,"given":"Nouri L.","family":"Ben Zakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Bollyky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-7060","authenticated-orcid":false,"given":"Jonathan R.","family":"Iredell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"1352_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"1352_CR2","unstructured":"O\u2019Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations (Wellcome Trust, 2016)."},{"key":"1352_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF01486931","volume":"28","author":"H Ruska","year":"1940","unstructured":"Ruska, H. Die Sichtbarmachung der bakteriophagen Lyse im \u00dcbermikroskop [German]. Naturwissenschaften 28, 45\u201346 (1940).","journal-title":"Naturwissenschaften"},{"key":"1352_CR4","first-page":"970","volume":"167","author":"F d\u2019Herelle","year":"1918","unstructured":"d\u2019Herelle, F. Sur le r\u00f4le du microbe filtrant bact\u00e9riophage dans la dysent\u00e9rie bacillaire [French]. C. R. Acad. Sci. 167, 970\u2013972 (1918).","journal-title":"C. R. Acad. Sci."},{"key":"1352_CR5","unstructured":"d\u2019H\u00e9relle, F. Le bact\u00e9riophage : Son r\u00f4le dans l\u2019immunit\u00e9 [French] (Masson et Cie, 1921)."},{"key":"1352_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03088-21","volume":"13","author":"A Angermeyer","year":"2021","unstructured":"Angermeyer, A. et al. Evolutionary sweeps of subviral parasites and their phage host bring unique parasite variants and disappearance of a phage CRISPR\u2013Cas system. mBio 13, e0308821 (2021).","journal-title":"mBio"},{"key":"1352_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41579-019-0311-5","volume":"18","author":"MB Dion","year":"2020","unstructured":"Dion, M. B., Oechslin, F. & Moineau, S. Phage diversity, genomics and phylogeny. Nat. Rev. Microbiol. 18, 125\u2013138 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"1352_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41564-022-01157-1","volume":"7","author":"D Piel","year":"2022","unstructured":"Piel, D. et al. Phage\u2013host coevolution in natural populations. Nat. Microbiol. 7, 1075\u20131086 (2022).","journal-title":"Nat. Microbiol."},{"key":"1352_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.1934.72750490003007","volume":"103","author":"MD Eaton","year":"1934","unstructured":"Eaton, M. D. & Bayne-Jones, S. Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA 103, 1769\u20131776 (1934).","journal-title":"JAMA"},{"key":"1352_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3389\/fmicb.2020.01056","volume":"11","author":"M \u017baczek","year":"2020","unstructured":"\u017baczek, M., Weber-D\u0105browska, B., Mi\u0119dzybrodzki, R., \u0141usiak-Szelachowska, M. & G\u00f3rski, A. Phage therapy in Poland\u2014a centennial journey to the first ethically approved treatment facility in Europe. Front. Microbiol. 11, 1056 (2020).","journal-title":"Front. Microbiol."},{"key":"1352_CR11","first-page":"PA5099","volume":"64","author":"M Dadiani","year":"2024","unstructured":"Dadiani, M., Nadareishvili, L., Nakaidze, N. & Nizharadze, D. Experience of Eliava Phage Therapy Center in the treatment of respiratory infections. Eur. Respir. J. 64, PA5099 (2024).","journal-title":"Eur. Respir. J."},{"key":"1352_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41564-019-0666-4","volume":"5","author":"RT Schooley","year":"2020","unstructured":"Schooley, R. T. & Strathdee, S. Treat phage like living antibiotics. Nat. Microbiol. 5, 391\u2013392 (2020).","journal-title":"Nat. Microbiol."},{"key":"1352_CR13","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1016\/j.cell.2024.09.009","volume":"187","author":"M Koncz","year":"2024","unstructured":"Koncz, M. et al. Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens. Cell 187, 5901\u20135918.e28 (2024).","journal-title":"Cell"},{"key":"1352_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202113936","volume":"13","author":"A Khatami","year":"2021","unstructured":"Khatami, A. et al. Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child. EMBO Mol. Med. 13, e13936 (2021).","journal-title":"EMBO Mol. Med."},{"key":"1352_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"1352_CR16","doi-asserted-by":"publisher","first-page":"00954","DOI":"10.1128\/AAC.00954-17","volume":"61","author":"RT Schooley","year":"2017","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61, 00954-17 https:\/\/doi.org\/10.1128\/AAC.00954-17 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1352_CR17","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.3390\/v13122414","volume":"13","author":"T Ferry","year":"2021","unstructured":"Ferry, T. et al. Past and future of phage therapy and phage-derived proteins in patients with bone and joint infection. Viruses 13, 2414 (2021).","journal-title":"Viruses"},{"key":"1352_CR18","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","volume":"22","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek, S. et al. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect. Dis. 22, e208\u2013e220 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1352_CR19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fmicb.2014.00734","volume":"5","author":"JML Bernard","year":"2014","unstructured":"Bernard, J. M. L. & Francis, M. B. Chemical strategies for the covalent modification of filamentous phage. Front. Microbiol. 5, 734 (2014).","journal-title":"Front. Microbiol."},{"key":"1352_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/v13030506","volume":"13","author":"D Turner","year":"2021","unstructured":"Turner, D., Kropinski, A. M. & Adriaenssens, E. M. A roadmap for genome-based phage taxonomy. Viruses 13, 506 https:\/\/doi.org\/10.3390\/v13030506 (2021).","journal-title":"Viruses"},{"key":"1352_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/j.1460-2075.1983.tb01433.x","volume":"2","author":"H Schwarz","year":"1983","unstructured":"Schwarz, H., Riede, I., Sonntag, I. & Henning, U. Degrees of relatedness of T-even type E. coli phages using different or the same receptors and topology of serologically cross-reacting sites. EMBO J. 2, 375\u2013380 (1983).","journal-title":"EMBO J."},{"key":"1352_CR22","doi-asserted-by":"publisher","first-page":"210188","DOI":"10.1098\/rsob.210188","volume":"11","author":"S Mantynen","year":"2021","unstructured":"M\u00e4ntynen, S., Laanto, E., Oksanen, H. M., Poranen, M. M. & D\u00edaz-Mu\u00f1oz, S. L. Black box of phage\u2013bacterium interactions: exploring alternative phage infection strategies. Open. Biol. 11, 210188 (2021).","journal-title":"Open. Biol."},{"key":"1352_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-virology-100114-055212","volume":"2","author":"VB Rao","year":"2015","unstructured":"Rao, V. B. & Feiss, M. Mechanisms of DNA packaging by large double-stranded DNA viruses. Annu. Rev. Virol. 2, 351\u2013378 (2015).","journal-title":"Annu. Rev. Virol."},{"key":"1352_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrmicro2632","volume":"9","author":"SR Casjens","year":"2011","unstructured":"Casjens, S. R. The DNA-packaging nanomotor of tailed bacteriophages. Nat. Rev. Microbiol. 9, 647\u2013657 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"1352_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1128\/jb.61.6.675-688.1951","volume":"61","author":"VJ Freeman","year":"1951","unstructured":"Freeman, V. J. Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae. J. Bacteriol. 61, 675\u2013688 (1951).","journal-title":"J. Bacteriol."},{"key":"1352_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1128\/br.17.4.269-337.1953","volume":"17","author":"A Lwoff","year":"1953","unstructured":"Lwoff, A. Lysogeny. Bacteriol. Rev. 17, 269\u2013337 (1953).","journal-title":"Bacteriol. Rev."},{"key":"1352_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0092-8674(02)00749-3","volume":"109","author":"BL Bassler","year":"2002","unstructured":"Bassler, B. L. Small talk: cell-to-cell communication in bacteria. Cell 109, 421\u2013424 (2002).","journal-title":"Cell"},{"key":"1352_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41564-021-01008-5","volume":"7","author":"N Aframian","year":"2022","unstructured":"Aframian, N. et al. Dormant phages communicate via arbitrium to control exit from lysogeny. Nat. Microbiol. 7, 145\u2013153 (2022).","journal-title":"Nat. Microbiol."},{"key":"1352_CR29","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fmicb.2016.01391","volume":"7","author":"D Bryan","year":"2016","unstructured":"Bryan, D., El-Shibiny, A., Hobbs, Z., Porter, J. & Kutter, E. M. Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front. Microbiol. 7, 1391 (2016).","journal-title":"Front. Microbiol."},{"key":"1352_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44157-3","volume":"15","author":"E Maffei","year":"2024","unstructured":"Maffei, E. et al. Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication. Nat. Commun. 15, 175 (2024).","journal-title":"Nat. Commun."},{"key":"1352_CR31","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1038\/ismej.2016.79","volume":"10","author":"J Bondy-Denomy","year":"2016","unstructured":"Bondy-Denomy, J. et al. Prophages mediate defense against phage infection through diverse mechanisms. ISME J. 10, 2854\u20132866 (2016).","journal-title":"ISME J."},{"key":"1352_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106007","volume":"26","author":"SG Sutcliffe","year":"2023","unstructured":"Sutcliffe, S. G., Reyes, A. & Maurice, C. F. Bacteriophages playing nice: lysogenic bacteriophage replication stable in the human gut microbiota. iScience 26, 106007 (2023).","journal-title":"iScience"},{"key":"1352_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2022.102229","volume":"70","author":"TL Brown","year":"2022","unstructured":"Brown, T. L., Charity, O. J. & Adriaenssens, E. M. Ecological and functional roles of bacteriophages in contrasting environments: marine, terrestrial and human gut. Curr. Opin. Microbiol. 70, 102229 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"1352_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","volume":"1","author":"MR Clokie","year":"2011","unstructured":"Clokie, M. R., Millard, A. D., Letarov, A. V. & Heaphy, S. Phages in nature. Bacteriophage 1, 31\u201345 (2011).","journal-title":"Bacteriophage"},{"key":"1352_CR35","doi-asserted-by":"publisher","first-page":"20150494","DOI":"10.1098\/rstb.2015.0494","volume":"371","author":"J Errington","year":"2016","unstructured":"Errington, J., Mickiewicz, K., Kawai, Y. & Wu, L. J. L-form bacteria, chronic diseases and the origins of life. Philos. Trans. R. Soc. Lond. B 371, 20150494 https:\/\/doi.org\/10.1098\/rstb.2015.0494 (2016).","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"key":"1352_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02419-22","volume":"10","author":"A Petrovic Fabijan","year":"2022","unstructured":"Petrovic Fabijan, A. et al. L-form switching in Escherichia coli as a common \u03b2-lactam resistance mechanism. Microbiol. Spectr. 10, e0241922 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1352_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-394621-8.00019-4","volume":"82","author":"M \u0141o\u015b","year":"2012","unstructured":"\u0141o\u015b, M. & Wegrzyn, G. Pseudolysogeny. Adv. Virus Res. 82, 339\u2013349 (2012).","journal-title":"Adv. Virus Res."},{"key":"1352_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41564-022-01317-3","volume":"8","author":"JC Wohlfarth","year":"2023","unstructured":"Wohlfarth, J. C. et al. L-form conversion in Gram-positive bacteria enables escape from phage infection. Nat. Microbiol. 8, 387\u2013399 (2023).","journal-title":"Nat. Microbiol."},{"key":"1352_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/jb.92.2.398-404.1966","volume":"92","author":"M Kawakami","year":"1966","unstructured":"Kawakami, M. & Landman, O. E. Retention of episomes during protoplasting and during propagation in the L state. J. Bacteriol. 92, 398\u2013404 (1966).","journal-title":"J. Bacteriol."},{"key":"1352_CR40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/microorganisms13061239","volume":"13","author":"T Mohammadi","year":"2025","unstructured":"Mohammadi, T. & Ely, B. Dolichocephalovirinae phages exist as episomal pseudolysogens across diverse soil bacteria. Microorganisms 13, 1239 (2025).","journal-title":"Microorganisms"},{"key":"1352_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4161\/viru.22351","volume":"3","author":"SM Faruque","year":"2012","unstructured":"Faruque, S. M. & Mekalanos, J. J. Phage\u2013bacterial interactions in the evolution of toxigenic Vibrio cholerae. Virulence 3, 556\u2013565 (2012).","journal-title":"Virulence"},{"key":"1352_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.aambs.2017.05.002","volume":"101","author":"LC Fortier","year":"2017","unstructured":"Fortier, L. C. The contribution of bacteriophages to the biology and virulence of pathogenic clostridia. Adv. Appl. Microbiol. 101, 169\u2013200 (2017).","journal-title":"Adv. Appl. Microbiol."},{"key":"1352_CR43","doi-asserted-by":"publisher","first-page":"goac012","DOI":"10.1093\/gastro\/goac012","volume":"10","author":"T Borodovich","year":"2022","unstructured":"Borodovich, T., Shkoporov, A., Ross, R. & Hill, C. Phage-mediated horizontal gene transfer and its implications for the human gut microbiome. Gastroenterol. Rep. 10, goac012 https:\/\/doi.org\/10.1093\/gastro\/goac012 (2022).","journal-title":"Gastroenterol. Rep."},{"key":"1352_CR44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/gutjnl-2017-313952","volume":"67","author":"T Zuo","year":"2018","unstructured":"Zuo, T. et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut 67, 634\u2013643 (2018).","journal-title":"Gut"},{"key":"1352_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fmicb.2014.00184","volume":"5","author":"KR Hargreaves","year":"2014","unstructured":"Hargreaves, K. R. & Clokie, M. R. Clostridium difficile phages: still difficult? Front. Microbiol. 5, 184 (2014).","journal-title":"Front. Microbiol."},{"key":"1352_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115369","volume":"44","author":"J Krusche","year":"2025","unstructured":"Krusche, J. et al. Characterization and host range prediction of Staphylococcus aureus phages through receptor-binding protein analysis. Cell Rep. 44, 115369 (2025).","journal-title":"Cell Rep."},{"key":"1352_CR47","doi-asserted-by":"publisher","first-page":"17390","DOI":"10.3390\/ijms242417390","volume":"24","author":"AV Letarov","year":"2023","unstructured":"Letarov, A. V. Bacterial virus forcing of bacterial O-antigen shields: lessons from coliphages. Int. J. Mol. Sci. 24, 17390 https:\/\/doi.org\/10.3390\/ijms242417390 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1352_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001424","volume":"19","author":"E Maffei","year":"2021","unstructured":"Maffei, E. et al. Systematic exploration of Escherichia coli phage\u2013host interactions with the BASEL phage collection. PLoS Biol. 19, e3001424 (2021).","journal-title":"PLoS Biol."},{"key":"1352_CR49","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.3390\/ijms23137084","volume":"23","author":"NC Esteves","year":"2022","unstructured":"Esteves, N. C. & Scharf, B. E. Flagellotropic bacteriophages: opportunities and challenges for antimicrobial applications. Int. J. Mol. Sci. 23, 7084 https:\/\/doi.org\/10.3390\/ijms23137084 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1352_CR50","doi-asserted-by":"publisher","first-page":"00325","DOI":"10.1128\/JVI.00325-20","volume":"94","author":"P Chen","year":"2020","unstructured":"Chen, P. et al. LamB, OmpC, and the core lipopolysaccharide of Escherichia coli K-12 function as receptors of bacteriophage Bp7. J. Virol. 94, 00325-20 https:\/\/doi.org\/10.1128\/JVI.00325-20 (2020).","journal-title":"J. Virol."},{"key":"1352_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57221-0","volume":"10","author":"T Holtzman","year":"2020","unstructured":"Holtzman, T. et al. A continuous evolution system for contracting the host range of bacteriophage T7. Sci. Rep. 10, 307 (2020).","journal-title":"Sci. Rep."},{"key":"1352_CR52","first-page":"1098","volume":"85","author":"R Appelmans","year":"1921","unstructured":"Appelmans, R. Le dosage du bact\u00e9riophage [French]. C. R. Soc. Biol. 85, 1098 (1921).","journal-title":"C. R. Soc. Biol."},{"key":"1352_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35203-7","volume":"13","author":"CF Arias","year":"2022","unstructured":"Arias, C. F., Acosta, F. J., Bertocchini, F., Herrero, M. A. & Fern\u00e1ndez-Arias, C. The coordination of anti-phage immunity mechanisms in bacterial cells. Nat. Commun. 13, 7412 (2022).","journal-title":"Nat. Commun."},{"key":"1352_CR54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41579-023-00934-x","volume":"21","author":"H Georjon","year":"2023","unstructured":"Georjon, H. & Bernheim, A. The highly diverse antiphage defence systems of bacteria. Nat. Rev. Microbiol. 21, 686\u2013700 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1352_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0065-2164(10)70007-1","volume":"70","author":"P Hyman","year":"2010","unstructured":"Hyman, P. & Abedon, S. T. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 70, 217\u2013248 (2010).","journal-title":"Adv. Appl. Microbiol."},{"key":"1352_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","volume":"8","author":"SJ Labrie","year":"2010","unstructured":"Labrie, S. J., Samson, J. E. & Moineau, S. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8, 317\u2013327 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"1352_CR57","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41564-025-02239-6","volume":"11","author":"TA Nagy","year":"2026","unstructured":"Nagy, T. A., Gersabeck, G. W., Conte, A. N. & Whiteley, A. T. A phage protein screen identifies triggers of the bacterial innate immune system. Nat. Microbiol. 11, 597\u2013609 (2026).","journal-title":"Nat. Microbiol."},{"key":"1352_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev.bi.38.070169.002343","volume":"38","author":"W Arber","year":"1969","unstructured":"Arber, W. & Linn, S. DNA modification and restriction. Annu. Rev. Biochem. 38, 467\u2013500 (1969).","journal-title":"Annu. Rev. Biochem."},{"key":"1352_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj0341","volume":"10","author":"AR Costa","year":"2024","unstructured":"Costa, A. R. et al. Accumulation of defense systems in phage-resistant strains of Pseudomonas aeruginosa. Sci. Adv. 10, eadj0341 (2024).","journal-title":"Sci. Adv."},{"key":"1352_CR60","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41564-024-01832-5","volume":"9","author":"B Gaborieau","year":"2024","unstructured":"Gaborieau, B. et al. Prediction of strain level phage\u2013host interactions across the Escherichia genus using only genomic information. Nat. Microbiol. 9, 2847\u20132861 (2024).","journal-title":"Nat. Microbiol."},{"key":"1352_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53994-9","volume":"15","author":"MK Kim","year":"2024","unstructured":"Kim, M. K. et al. A blueprint for broadly effective bacteriophage\u2013antibiotic cocktails against bacterial infections. Nat. Commun. 15, 9987 (2024).","journal-title":"Nat. Commun."},{"key":"1352_CR62","doi-asserted-by":"publisher","unstructured":"M\u00fcller, D. M. et al. Bacterial receptors but not anti-phage defence mechanisms determine host range for a pair of Pseudomonas aeruginosa lytic phages. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.04.30.591980 (2026).","DOI":"10.1101\/2024.04.30.591980"},{"key":"1352_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2025.102696","volume":"89","author":"N Torriero-Smith","year":"2026","unstructured":"Torriero-Smith, N., Rogers, B. A., McDonald, M. J. & Barr, J. J. Harnessing \u2018phage training\u2019 to bolster the therapeutic potential of bacteriophages. Curr. Opin. Microbiol. 89, 102696 (2026).","journal-title":"Curr. Opin. Microbiol."},{"key":"1352_CR64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J. Nanobiotechnol. 22, 365 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"1352_CR65","first-page":"1","volume":"1","author":"L Van Valen","year":"1973","unstructured":"Van Valen, L. A new evolutionary law. Evol. Theory 1, 1\u201330 (1973).","journal-title":"Evol. Theory"},{"key":"1352_CR66","first-page":"703","volume":"215","author":"F Oechslin","year":"2017","unstructured":"Oechslin, F. et al. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J. Infect. Dis. 215, 703\u2013712 (2017).","journal-title":"J. Infect. Dis."},{"key":"1352_CR67","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","volume":"5","author":"A Petrovic Fabijan","year":"2020","unstructured":"Petrovic Fabijan, A. et al. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol. 5, 465\u2013472 (2020).","journal-title":"Nat. Microbiol."},{"key":"1352_CR68","doi-asserted-by":"publisher","first-page":"00877","DOI":"10.1128\/mSystems.00877-19","volume":"5","author":"EL Simmons","year":"2020","unstructured":"Simmons, E. L. et al. Biofilm structure promotes coexistence of phage-resistant and phage-susceptible bacteria. mSystems 5, 00877-19 https:\/\/doi.org\/10.1128\/mSystems.00877-19 (2020).","journal-title":"mSystems"},{"key":"1352_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-virology-091919-074222","volume":"8","author":"DP Pires","year":"2021","unstructured":"Pires, D. P., Melo, L. D. R. & Azeredo, J. Understanding the complex phage\u2013host interactions in biofilm communities. Annu. Rev. Virol. 8, 73\u201394 (2021).","journal-title":"Annu. Rev. Virol."},{"key":"1352_CR70","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/v14051057","volume":"14","author":"A Visnapuu","year":"2022","unstructured":"Visnapuu, A., Van der Gucht, M., Wagemans, J. & Lavigne, R. Deconstructing the phage\u2013bacterial biofilm interaction as a basis to establish new antibiofilm strategies. Viruses 14, 1057 https:\/\/doi.org\/10.3390\/v14051057 (2022).","journal-title":"Viruses"},{"key":"1352_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1753740","volume":"16","author":"M Bowder","year":"2026","unstructured":"Bowder, M., Kapoor, H., Carrell, S. J. & Danelishvili, L. Phage isolation and functional characterization reveal strong antibiofilm activity against Pseudomonas aeruginosa in a cystic fibrosis sputum model. Front. Cell Infect. Microbiol. 16, 1753740 (2026).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1352_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110372","volume":"38","author":"H Hendrix","year":"2022","unstructured":"Hendrix, H. et al. Metabolic reprogramming of Pseudomonas aeruginosa by phage-based quorum sensing modulation. Cell Rep. 38, 110372 (2022).","journal-title":"Cell Rep."},{"key":"1352_CR73","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10096-025-05375-3","volume":"45","author":"L Fern\u00e1ndez-Garcia","year":"2026","unstructured":"Fern\u00e1ndez-Garcia, L. et al. Phages and quorum sensing: findings to consider in phage therapy. Eur. J. Clin. Microbiol. Infect. Dis. 45, 615\u2013629 (2026).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"1352_CR74","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nature09905","volume":"472","author":"RE Beardmore","year":"2011","unstructured":"Beardmore, R. E., Gudelj, I., Lipson, D. A. & Hurst, L. D. Metabolic trade-offs and the maintenance of the fittest and the flattest. Nature 472, 342\u2013346 (2011).","journal-title":"Nature"},{"key":"1352_CR75","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1469-0691.2010.03250.x","volume":"16","author":"A Oliver","year":"2010","unstructured":"Oliver, A. & Mena, A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16, 798\u2013808 (2010).","journal-title":"Clin. Microbiol. Infect."},{"key":"1352_CR76","unstructured":"d, He\u0301relle, F. Le bacte\u0301riophage et ses applications the\u0301rapeutiques [French] (Doin, 1933)."},{"key":"1352_CR77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00000441-193602000-00004","volume":"191","author":"WJ Macneal","year":"1936","unstructured":"MacNeal, W. J. & Frisbee, F. C. One hundred patients with Staphylococcus septicemia receiving bacteriphage service. Am. J. Med. Sci. 191, 179\u2013195 (1936).","journal-title":"Am. J. Med. Sci."},{"key":"1352_CR78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","volume":"34","author":"A Wright","year":"2009","unstructured":"Wright, A., Hawkins, C. H., Anggard, E. E. & Harper, D. R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 34, 349\u2013357 (2009).","journal-title":"Clin. Otolaryngol."},{"key":"1352_CR79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault, P. et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect. Dis. 19, 35\u201345 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1352_CR80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","volume":"21","author":"L Leitner","year":"2021","unstructured":"Leitner, L. et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect. Dis. 21, 427\u2013436 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1352_CR81","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","volume":"4","author":"SA Sarker","year":"2016","unstructured":"Sarker, S. A. et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. eBioMedicine 4, 124\u2013137 (2016).","journal-title":"eBioMedicine"},{"key":"1352_CR82","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","volume":"18","author":"Adaptive Platform Trials Coalition.","year":"2019","unstructured":"Adaptive Platform Trials Coalition. Adaptive platform trials: definition, design, conduct and reporting considerations. Nat. Rev. Drug. Discov. 18, 797\u2013807 (2019).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1352_CR83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2023","unstructured":"Dedrick, R. M. et al. Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin. Infect. Dis. 76, 103\u2013112 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1352_CR84","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay, J. P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol. 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol."},{"key":"1352_CR85","first-page":"68","volume":"4","author":"DN Kok","year":"2023","unstructured":"Kok, D. N., Turnbull, J., Takeuchi, N., Tsourkas, P. K. & Hendrickson, H. L. In vitro evolution to increase the titers of difficult bacteriophages: RAMP-UP protocol. Phage 4, 68\u201381 (2023).","journal-title":"Phage"},{"key":"1352_CR86","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/antibiotics9060291","volume":"9","author":"E Laanto","year":"2020","unstructured":"Laanto, E., M\u00e4kel\u00e4, K., Hoikkala, V., Ravantti, J. J. & Sundberg, L.-R. Adapting a phage to combat phage resistance. Antibiotics 9, 291 https:\/\/doi.org\/10.3390\/antibiotics9060291 (2020).","journal-title":"Antibiotics"},{"key":"1352_CR87","doi-asserted-by":"publisher","first-page":"e2104592118","DOI":"10.1073\/pnas.2104592118","volume":"118","author":"JM Borin","year":"2021","unstructured":"Borin, J. M., Avrani, S., Barrick, J. E., Petrie, K. L. & Meyer, J. R. Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance. Proc. Natl Acad. Sci. USA 118, e2104592118 https:\/\/doi.org\/10.1073\/pnas.2104592118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1352_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016963","volume":"6","author":"E Morello","year":"2011","unstructured":"Morello, E. et al. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS ONE 6, e16963 (2011).","journal-title":"PLoS ONE"},{"key":"1352_CR89","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2019.09.015","volume":"179","author":"K Yehl","year":"2019","unstructured":"Yehl, K. et al. Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis. Cell 179, 459\u2013469.e9 (2019).","journal-title":"Cell"},{"key":"1352_CR90","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","volume":"42","author":"YE Gencay","year":"2024","unstructured":"Gencay, Y. E. et al. Engineered phage with antibacterial CRISPR\u2013Cas selectively reduce E. coli burden in mice. Nat. Biotechnol. 42, 265\u2013274 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1352_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1000721","volume":"12","author":"V Daubie","year":"2022","unstructured":"Daubie, V. et al. Determination of phage susceptibility as a clinical diagnostic tool: a routine perspective. Front. Cell Infect. Microbiol. 12, 1000721 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1352_CR92","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000036","volume":"1","author":"N Ramesh","year":"2019","unstructured":"Ramesh, N., Archana, L., Madurantakam Royam, M., Manohar, P. & Eniyan, K. Effect of various bacteriological media on the plaque morphology of Staphylococcus and Vibrio phages. Access Microbiol. 1, e000036 (2019).","journal-title":"Access Microbiol."},{"key":"1352_CR93","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1016\/j.jmb.2020.06.013","volume":"432","author":"IV Krieger","year":"2020","unstructured":"Krieger, I. V. et al. The structural basis of T4 phage lysis control: DNA as the signal for lysis inhibition. J. Mol. Biol. 432, 4623\u20134636 (2020).","journal-title":"J. Mol. Biol."},{"key":"1352_CR94","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00614-23","volume":"61","author":"K Parmar","year":"2023","unstructured":"Parmar, K. et al. Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing. J. Clin. Microbiol. 61, e0061423 (2023).","journal-title":"J. Clin. Microbiol."},{"key":"1352_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48675-6","volume":"15","author":"D Boeckaerts","year":"2024","unstructured":"Boeckaerts, D. et al. Prediction of Klebsiella phage\u2013host specificity at the strain level. Nat. Commun. 15, 4355 (2024).","journal-title":"Nat. Commun."},{"key":"1352_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1148579","volume":"14","author":"S Aggarwal","year":"2023","unstructured":"Aggarwal, S. et al. An ensemble method for prediction of phage-based therapy against bacterial infections. Front. Microbiol. 14, 1148579 (2023).","journal-title":"Front. Microbiol."},{"key":"1352_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003063","volume":"23","author":"D Humolli","year":"2025","unstructured":"Humolli, D. et al. Completing the BASEL phage collection to unlock hidden diversity for systematic exploration of phage\u2013host interactions. PLoS Biol. 23, e3003063 (2025).","journal-title":"PLoS Biol."},{"key":"1352_CR98","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","volume":"8","author":"BK Chan","year":"2013","unstructured":"Chan, B. K., Abedon, S. T. & Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol. 8, 769\u2013783 (2013).","journal-title":"Future Microbiol."},{"key":"1352_CR99","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan, B. K. et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat. Med. 31, 1494\u20131501 (2025).","journal-title":"Nat. Med."},{"key":"1352_CR100","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/18913","volume":"398","author":"PE Turner","year":"1999","unstructured":"Turner, P. E. & Chao, L. Prisoner\u2019s dilemma in an RNA virus. Nature 398, 441\u2013443 (1999).","journal-title":"Nature"},{"key":"1352_CR101","doi-asserted-by":"publisher","DOI":"10.1093\/ismejo\/wrag067","volume":"20","author":"BA van der Steen","year":"2026","unstructured":"van der Steen, B. A., Gralka, M. & Mulla, Y. Rapid resistance evolution against phage cocktails. ISME J. 20, wrag067 (2026).","journal-title":"ISME J."},{"key":"1352_CR102","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.1073\/pnas.1919888117","volume":"117","author":"AR Burmeister","year":"2020","unstructured":"Burmeister, A. R. et al. Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc. Natl Acad. Sci. USA 117, 11207\u201311216 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1352_CR103","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1111\/1462-2920.15476","volume":"23","author":"G Majkowska-Skrobek","year":"2021","unstructured":"Majkowska-Skrobek, G. et al. The evolutionary trade-offs in phage-resistant Klebsiella pneumoniae entail cross-phage sensitization and loss of multidrug resistance. Environ. Microbiol. 23, 7723\u20137740 (2021).","journal-title":"Environ. Microbiol."},{"key":"1352_CR104","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1128\/AAC.01275-10","volume":"55","author":"YK Tsai","year":"2011","unstructured":"Tsai, Y. K. et al. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob. Agents Chemother. 55, 1485\u20131493 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1352_CR105","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/ph14101019","volume":"14","author":"ST Abedon","year":"2021","unstructured":"Abedon, S. T., Danis-Wlodarczyk, K. M. & Wozniak, D. J. Phage cocktail development for bacteriophage therapy: toward improving spectrum of activity breadth and depth. Pharmaceuticals 14, 1019 https:\/\/doi.org\/10.3390\/ph14101019 (2021).","journal-title":"Pharmaceuticals"},{"key":"1352_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031698","volume":"7","author":"J Gu","year":"2012","unstructured":"Gu, J. et al. A method for generation phage cocktail with great therapeutic potential. PLoS ONE 7, e31698 (2012).","journal-title":"PLoS ONE"},{"key":"1352_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.564532","volume":"12","author":"F Molina","year":"2021","unstructured":"Molina, F. et al. A new pipeline for designing phage cocktails based on phage\u2013bacteria infection networks. Front. Microbiol. 12, 564532 (2021).","journal-title":"Front. Microbiol."},{"key":"1352_CR108","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/antibiotics8040182","volume":"8","author":"ST Abedon","year":"2019","unstructured":"Abedon, S. T. Phage\u2013antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy? Antibiotics 8, 182 https:\/\/doi.org\/10.3390\/antibiotics8040182 (2019).","journal-title":"Antibiotics"},{"key":"1352_CR109","doi-asserted-by":"publisher","first-page":"04162","DOI":"10.1128\/mBio.01462-20","volume":"11","author":"CG Liu","year":"2020","unstructured":"Liu, C. G. et al. Phage\u2013antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio 11, 04162-20 https:\/\/doi.org\/10.1128\/mBio.01462-20 (2020).","journal-title":"mBio"},{"key":"1352_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104045","volume":"80","author":"FL Gordillo Altamirano","year":"2022","unstructured":"Gordillo Altamirano, F. L. et al. Phage\u2013antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. eBioMedicine 80, 104045 (2022).","journal-title":"eBioMedicine"},{"key":"1352_CR111","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023080","volume":"11","author":"J Save","year":"2022","unstructured":"Save, J. et al. Bacteriophages combined with subtherapeutic doses of flucloxacillin act synergistically against Staphylococcus aureus experimental infective endocarditis. J. Am. Heart Assoc. 11, e023080 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"1352_CR112","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065401","volume":"12","author":"A Khatami","year":"2022","unstructured":"Khatami, A. et al. Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial. BMJ Open 12, e065401 (2022).","journal-title":"BMJ Open"},{"key":"1352_CR113","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/v15112211","volume":"15","author":"JE Egido","year":"2023","unstructured":"Egido, J. E. et al. Human complement inhibits myophages against Pseudomonas aeruginosa. Viruses 15, 2211 https:\/\/doi.org\/10.3390\/v15112211 (2023).","journal-title":"Viruses"},{"key":"1352_CR114","first-page":"91","volume":"1","author":"K Hodyra-Stefaniak","year":"2020","unstructured":"Hodyra-Stefaniak, K. et al. Natural and induced antibodies against phages in humans: induction kinetics and immunogenicity for structural proteins of PB1-related phages. Phage 1, 91\u201399 (2020).","journal-title":"Phage"},{"key":"1352_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/srep14802","volume":"5","author":"K Hodyra-Stefaniak","year":"2015","unstructured":"Hodyra-Stefaniak, K. et al. Mammalian host-versus-phage immune response determines phage fate in vivo. Sci. Rep. 5, 14802 (2015).","journal-title":"Sci. Rep."},{"key":"1352_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000253","volume":"5","author":"BJ Cairns","year":"2009","unstructured":"Cairns, B. J., Timms, A. R., Jansen, V. A. A., Connerton, I. F. & Payne, R. J. H. Quantitative models of in vitro bacteriophage\u2013host dynamics and their application to phage therapy. PLoS Pathog. 5, e1000253 (2009).","journal-title":"PLoS Pathog."},{"key":"1352_CR117","doi-asserted-by":"publisher","first-page":"13123","DOI":"10.1128\/JVI.76.24.13123-13124.2002","volume":"76","author":"RJH Payne","year":"2002","unstructured":"Payne, R. J. H. & Jansen, V. A. A. Evidence for a phage proliferation threshold? J. Virol. 76, 13123\u201313124 (2002).","journal-title":"J. Virol."},{"key":"1352_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1012242","volume":"20","author":"U Hvid","year":"2024","unstructured":"Hvid, U. & Mitarai, N. Competitive advantages of T-even phage lysis inhibition in response to secondary infection. PLoS Comput. Biol. 20, e1012242 (2024).","journal-title":"PLoS Comput. Biol."},{"key":"1352_CR119","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1128\/JCM.41.9.4160-4165.2003","volume":"41","author":"AR Falsey","year":"2003","unstructured":"Falsey, A. R., Formica, M. A., Treanor, J. J. & Walsh, E. E. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J. Clin. Microbiol. 41, 4160\u20134165 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"1352_CR120","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/319351","volume":"2014","author":"H Liu","year":"2014","unstructured":"Liu, H., Niu, Y. D., Li, J., Stanford, K. & McAllister, T. A. Rapid and accurate detection of bacteriophage activity against Escherichia coli O157:H7 by propidium monoazide real-time PCR. Biomed. Res. Int. 2014, 319351 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1352_CR121","doi-asserted-by":"publisher","first-page":"S384","DOI":"10.1093\/cid\/ciad497","volume":"77","author":"K Bosco","year":"2023","unstructured":"Bosco, K., Lynch, S., Sandaradura, I. & Khatami, A. Therapeutic phage monitoring: a review. Clin. Infect. Dis. 77, S384\u2013S394 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1352_CR122","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/nyas.14034","volume":"1441","author":"LH Kahn","year":"2019","unstructured":"Kahn, L. H. et al. From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture. Ann. N. Y. Acad. Sci. 1441, 31\u201339 (2019).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1352_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107758","volume":"49","author":"J Jo\u00e3o","year":"2021","unstructured":"Jo\u00e3o, J., Lampreia, J., Prazeres, D. M. F. & Azevedo, A. M. Manufacturing of bacteriophages for therapeutic applications. Biotechnol. Adv. 49, 107758 (2021).","journal-title":"Biotechnol. Adv."},{"key":"1352_CR124","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5582\/irdr.2016.01054","volume":"5","author":"G Balasubramanian","year":"2016","unstructured":"Balasubramanian, G., Morampudi, S., Chhabra, P., Gowda, A. & Zomorodi, B. An overview of compassionate use programs in the European Union member states. Intractable Rare Dis. Res. 5, 244\u2013254 (2016).","journal-title":"Intractable Rare Dis. Res."},{"key":"1352_CR125","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1093\/cid\/ciad481","volume":"77","author":"JP Pirnay","year":"2023","unstructured":"Pirnay, J. P. & Verbeken, G. Magistral phage preparations: is this the model for everyone? Clin. Infect. Dis. 77, S360\u2013S369 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1352_CR126","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02071-21","volume":"66","author":"GA Suh","year":"2022","unstructured":"Suh, G. A. et al. Considerations for the use of phage therapy in clinical practice. Antimicrob. Agents Chemother. 66, e0207121 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1352_CR127","unstructured":"Science, Innovation and Technology Committee. The antimicrobial potential of bacteriophages. UK Parliament https:\/\/publications.parliament.uk\/pa\/cm5804\/cmselect\/cmsctech\/328\/report.html (2024)."},{"key":"1352_CR128","unstructured":"Iredell, J. & Sacher, J. Investing in the future of phage therapy. REVIVE https:\/\/revive.gardp.org\/investing-in-the-future-of-phage-therapy\/ (2023)."},{"key":"1352_CR129","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/v13050865","volume":"13","author":"H Duyvejonck","year":"2021","unstructured":"Duyvejonck, H. et al. Evaluation of the stability of bacteriophages in different solutions suitable for the production of magistral preparations in Belgium. Viruses 13, 865 https:\/\/doi.org\/10.3390\/v13050865 (2021).","journal-title":"Viruses"},{"key":"1352_CR130","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3390\/pharmaceutics14091936","volume":"14","author":"M Wdowiak","year":"2022","unstructured":"Wdowiak, M., Paczesny, J. & Raza, S. Enhancing the stability of bacteriophages using physical, chemical, and nano-based approaches: a review. Pharmaceutics 14, 1936 https:\/\/doi.org\/10.3390\/pharmaceutics14091936 (2022).","journal-title":"Pharmaceutics"},{"key":"1352_CR131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3947\/ic.2023.0067","volume":"56","author":"S Lee","year":"2024","unstructured":"Lee, S., Lynch, S., Lin, R. C. Y., Myung, H. & Iredell, J. R. Phage therapy in Korea: a prescribers\u2019 survey of attitudes amongst Korean infectious diseases specialists towards phage therapy. Infect. Chemother. 56, 57\u201365 (2024).","journal-title":"Infect. Chemother."},{"key":"1352_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107579","volume":"66","author":"M Plymoth","year":"2025","unstructured":"Plymoth, M. et al. Attitudes to phage therapy among Australian infectious diseases physicians. Int. J. Antimicrob. Agents 66, 107579 (2025).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl","key":"1352_CR133","first-page":"S9","volume":"27","author":"K Harvey","year":"2003","unstructured":"Harvey, K., Dartnell, J. & Hemming, M. Improving antibiotic use: 25\u2009years of antibiotic guidelines and related initiatives. Commun. Dis. Intell. Q. Rep. 27 (Suppl), S9\u2013S12 (2003).","journal-title":"Commun. Dis. Intell. Q. Rep."},{"key":"1352_CR134","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47, 1181\u20131247 (2021).","journal-title":"Intensive Care Med."},{"key":"1352_CR135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg2703","volume":"11","author":"MF Flajnik","year":"2010","unstructured":"Flajnik, M. F. & Kasahara, M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat. Rev. Genet. 11, 47\u201359 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"1352_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002341","volume":"21","author":"MC Bichet","year":"2023","unstructured":"Bichet, M. C. et al. Mammalian cells internalize bacteriophages and use them as a resource to enhance cellular growth and survival. PLoS Biol. 21, e3002341 (2023).","journal-title":"PLoS Biol."},{"key":"1352_CR137","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2672.2004.02422.x","volume":"98","author":"K Dabrowska","year":"2005","unstructured":"Dabrowska, K., Swita\u0142a-Jelen, K., Opolski, A., Weber-Dabrowska, B. & Gorski, A. Bacteriophage penetration in vertebrates. J. Appl. Microbiol. 98, 7\u201313 (2005).","journal-title":"J. Appl. Microbiol."},{"key":"1352_CR138","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nri2301","volume":"8","author":"E Bell","year":"2008","unstructured":"Bell, E. TLR4 signalling. Nat. Rev. Immunol. 8, 241 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1352_CR139","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nri1226","volume":"3","author":"K Shuai","year":"2003","unstructured":"Shuai, K. & Liu, B. Regulation of JAK\u2013STAT signalling in the immune system. Nat. Rev. Immunol. 3, 900\u2013911 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"1352_CR140","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","volume":"670","author":"JM Platnich","year":"2019","unstructured":"Platnich, J. M. & Muruve, D. A. NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways. Arch. Biochem. Biophys. 670, 4\u201314 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"1352_CR141","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67\u201393 (2009).","journal-title":"Annu. Rev. Genet."},{"key":"1352_CR142","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nri2035","volume":"7","author":"Y Liu","year":"2007","unstructured":"Liu, Y., Shepherd, E. G. & Nelin, L. D. MAPK phosphatases\u2014regulating the immune response. Nat. Rev. Immunol. 7, 202\u2013212 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1352_CR143","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.4049\/jimmunol.0800224","volume":"182","author":"F Eriksson","year":"2009","unstructured":"Eriksson, F. et al. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. J. Immunol. 182, 3105\u20133111 (2009).","journal-title":"J. Immunol."},{"key":"1352_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08336-9","volume":"7","author":"JD Van Belleghem","year":"2017","unstructured":"Van Belleghem, J. D., Clement, F., Merabishvili, M., Lavigne, R. & Vaneechoutte, M. Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci. Rep. 7, 8004 (2017).","journal-title":"Sci. Rep."},{"key":"1352_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86202-5","volume":"11","author":"T Ueno","year":"2021","unstructured":"Ueno, T., Yamamoto, Y. & Kawasaki, K. Phagocytosis of microparticles increases responsiveness of macrophage-like cell lines U937 and THP-1 to bacterial lipopolysaccharide and lipopeptide. Sci. Rep. 11, 6782 (2021).","journal-title":"Sci. Rep."},{"key":"1352_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson, J. D. et al. Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model. Nat. Commun. 15, 2993 (2024).","journal-title":"Nat. Commun."},{"key":"1352_CR147","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1146\/annurev-virology-111821-111322","volume":"10","author":"L Kan","year":"2023","unstructured":"Kan, L. & Barr, J. J. A mammalian cell\u2019s guide on how to process a bacteriophage. Annu. Rev. Virol. 10, 183\u2013198 (2023).","journal-title":"Annu. Rev. Virol."},{"key":"1352_CR148","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2524540","volume":"17","author":"X Hou","year":"2025","unstructured":"Hou, X. et al. Gut bacteriophages induce specific-reprogramming of macrophages to generate a protective innate immunity response to lipopolysaccharide exposure. Gut Microbes 17, 2524540 (2025).","journal-title":"Gut Microbes"},{"key":"1352_CR149","doi-asserted-by":"publisher","first-page":"e00792","DOI":"10.1128\/JB.00792-17","volume":"200","author":"T Reyes-Robles","year":"2018","unstructured":"Reyes-Robles, T. et al. Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. J. Bacteriol. 200, e00792-17 (2018).","journal-title":"J. Bacteriol."},{"key":"1352_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1250339","volume":"13","author":"N Pennetzdorfer","year":"2023","unstructured":"Pennetzdorfer, N. et al. Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection. Front. Cell Infect. Microbiol. 13, 1250339 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1352_CR151","first-page":"223","volume":"1","author":"A Mohan","year":"2020","unstructured":"Mohan, A. & Saxena, H. M. Effect of phage targeting therapy of brucellosis on host antibody response in cattle. Phage 1, 223\u2013229 (2020).","journal-title":"Phage"},{"key":"1352_CR152","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cels.2020.02.006","volume":"10","author":"K Bodner","year":"2020","unstructured":"Bodner, K. et al. Engineered fluorescent E. coli lysogens allow live-cell imaging of functional prophage induction triggered inside macrophages. Cell Syst. 10, 254\u2013264.e9 (2020).","journal-title":"Cell Syst."},{"key":"1352_CR153","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","volume":"22","author":"DR Roach","year":"2017","unstructured":"Roach, D. R. et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 22, 38\u201347 e34 (2017).","journal-title":"Cell Host Microbe"},{"key":"1352_CR154","unstructured":"Dhakal, A. & Sbar, E. Jarisch\u2013Herxheimer Reaction (StatPearls, 2024)."},{"key":"1352_CR155","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2020.00244","volume":"11","author":"PR Secor","year":"2020","unstructured":"Secor, P. R. et al. Pf bacteriophage and their impact on pseudomonas virulence, mammalian immunity, and chronic infections. Front. Immunol. 11, 244 (2020).","journal-title":"Front. Immunol."},{"key":"1352_CR156","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/microorganisms11092222","volume":"11","author":"EB de Souza","year":"2023","unstructured":"de Souza, E. B., Pinto, A. R. & Fongaro, G. Bacteriophages as potential clinical immune modulators. Microorganisms 11, 2222\u00a0https:\/\/doi.org\/10.3390\/microorganisms11092222 (2023).","journal-title":"Microorganisms"},{"key":"1352_CR157","doi-asserted-by":"publisher","first-page":"eaat9691","DOI":"10.1126\/science.aat9691","volume":"363","author":"JM Sweere","year":"2019","unstructured":"Sweere, J. M. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 363, eaat9691 https:\/\/doi.org\/10.1126\/science.aat9691 (2019).","journal-title":"Science"},{"key":"1352_CR158","first-page":"437","volume":"7","author":"MK Mirzaei","year":"2016","unstructured":"Mirzaei, M. K. et al. Morphologically distinct Escherichia coli bacteriophages differ in their efficacy and ability to stimulate cytokine release in vitro. Front. Microbiol. 7, 437 (2016).","journal-title":"Front. Microbiol."},{"key":"1352_CR159","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1007\/s00253-017-8504-1","volume":"101","author":"JR Shiley","year":"2017","unstructured":"Shiley, J. R., Comfort, K. K. & Robinson, J. B. Immunogenicity and antimicrobial effectiveness of Pseudomonas aeruginosa specific bacteriophage in a human lung in vitro model. Appl. Microbiol. Biotechnol. 101, 7977\u20137985 (2017).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1352_CR160","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fimmu.2024.1405376","volume":"15","author":"R Nickerson","year":"2024","unstructured":"Nickerson, R., Thornton, C. S., Johnston, B., Lee, A. H. Y. & Cheng, Z. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response. Front. Immunol. 15, 2024 (2024).","journal-title":"Front. Immunol."},{"key":"1352_CR161","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01359-23","volume":"98","author":"X Tan","year":"2024","unstructured":"Tan, X. et al. Evaluation of the impact of repeated intravenous phage doses on mammalian host\u2013phage interactions. J. Virol. 98, e0135923 (2024).","journal-title":"J. Virol."},{"key":"1352_CR162","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/infdis\/jiac368","volume":"227","author":"JM Dan","year":"2023","unstructured":"Dan, J. M. et al. Development of host immune response to bacteriophage in a lung transplant recipient on adjunctive phage therapy for a multidrug-resistant pneumonia. J. Infect. Dis. 227, 311\u2013316 (2023).","journal-title":"J. Infect. Dis."},{"key":"1352_CR163","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2217\/fmb-2016-0156","volume":"12","author":"M \u0141usiak-Szelachowska","year":"2017","unstructured":"\u0141usiak-Szelachowska, M. et al. Antiphage activity of sera during phage therapy in relation to its outcome. Future Microbiol. 12, 109\u2013117 (2017).","journal-title":"Future Microbiol."},{"key":"1352_CR164","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3389\/fmicb.2016.01681","volume":"7","author":"M \u017baczek","year":"2016","unstructured":"\u017baczek, M. et al. Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy. Front. Microbiol. 7, 1681 (2016).","journal-title":"Front. Microbiol."},{"key":"1352_CR165","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","volume":"27","author":"RM Dedrick","year":"2021","unstructured":"Dedrick, R. M. et al. Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection. Nat. Med. 27, 1357\u20131361 (2021).","journal-title":"Nat. Med."},{"key":"1352_CR166","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.201904-0839LE","volume":"200","author":"S Maddocks","year":"2019","unstructured":"Maddocks, S. et al. Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 200, 1179\u20131181 https:\/\/doi.org\/10.1164\/rccm.201904-0839LE (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1352_CR167","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","volume":"31","author":"K Champagne-Jorgensen","year":"2023","unstructured":"Champagne-Jorgensen, K., Luong, T., Darby, T. & Roach, D. R. Immunogenicity of bacteriophages. Trends Microbiol. 31, 1058\u20131071 (2023).","journal-title":"Trends Microbiol."},{"key":"1352_CR168","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01736-21","volume":"9","author":"J Onsea","year":"2021","unstructured":"Onsea, J. et al. Bacteriophage therapy for the prevention and treatment of fracture-related infection caused by Staphylococcus aureus: a preclinical study. Microbiol. Spectr. 9, e0173621 (2021).","journal-title":"Microbiol. Spectr."},{"key":"1352_CR169","first-page":"553","volume":"35","author":"A Kucharewicz-Krukowska","year":"1987","unstructured":"Kucharewicz-Krukowska, A. & Slopek, S. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35, 553\u2013561 (1987).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"1352_CR170","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1093\/cid\/ciad515","volume":"77","author":"A Fajardo-Lubian","year":"2023","unstructured":"Fajardo-Lubian, A. & Venturini, C. Use of bacteriophages to target intracellular pathogens. Clin. Infect. Dis. 77, S423\u2013S432 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1352_CR171","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF01964420","volume":"10","author":"PM Tulkens","year":"1991","unstructured":"Tulkens, P. M. Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 10, 100\u2013106 (1991).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"1352_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38453-7","volume":"13","author":"M Mardiana","year":"2023","unstructured":"Mardiana, M. et al. Characterization of a novel and active temperate phage vB_AbaM_ABMM1 with antibacterial activity against Acinetobacter baumannii infection. Sci. Rep. 13, 11347 (2023).","journal-title":"Sci. Rep."},{"key":"1352_CR173","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","volume":"27","author":"R Monteiro","year":"2019","unstructured":"Monteiro, R., Pires, D. P., Costa, A. R. & Azeredo, J. Phage therapy: going temperate? Trends Microbiol. 27, 368\u2013378 (2019).","journal-title":"Trends Microbiol."},{"key":"1352_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107570","volume":"66","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Clinical application of customized and non-customized bacteriophage therapy in patients with refractory\/resistant bacterial infections: a systematic review and meta-analysis. Int. J. Antimicrob. Agents 66, 107570 (2025).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1352_CR175","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/antibiotics11101311","volume":"11","author":"TN Luxton","year":"2022","unstructured":"Luxton, T. N., King, N., Walti, C., Jeuken, L. J. C. & Sandoe, J. A. T. A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with carbapenems. Antibiotics 11, 1311 https:\/\/doi.org\/10.3390\/antibiotics11101311 (2022).","journal-title":"Antibiotics"},{"key":"1352_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tpb.2025.12.001","volume":"167","author":"MM Tanaka","year":"2026","unstructured":"Tanaka, M. M. & Wahl, L. M. What drives bacterial extinction? The role of bacteriophages. Theor. Popul. Biol. 167, 1\u201310 (2026).","journal-title":"Theor. Popul. Biol."},{"key":"1352_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127704","volume":"14","author":"M Strzelec","year":"2023","unstructured":"Strzelec, M., Detka, J., Mieszczak, P., Soboci\u0144ska, M. K. & Majka, M. Immunomodulation \u2014 a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Front. Immunol. 14, 1127704 (2023).","journal-title":"Front. Immunol."},{"key":"1352_CR178","first-page":"77","volume":"45","author":"LM Mar\u010duk","year":"1971","unstructured":"Mar\u010duk, L. M. et al. Clinical studies of the use of bacteriophage in the treatment of cholera. Bull. World Health Organ. 45, 77\u201383 (1971).","journal-title":"Bull. World Health Organ."},{"key":"1352_CR179","doi-asserted-by":"publisher","DOI":"10.1177\/15347346231226342","author":"SL Karn","year":"2024","unstructured":"Karn, S. L. et al. A randomized, placebo-controlled, double-blind clinical trial of bacteriophage cocktails in chronic wound infections. Int. J. Low. Extrem. Wounds https:\/\/doi.org\/10.1177\/15347346231226342 (2024).","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"1352_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104486","volume":"84","author":"HR Samaee","year":"2023","unstructured":"Samaee, H. R. et al. Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: a double-blind clinical trial study. J. Drug. Deliv. Sci. Technol. 84, 104486 (2023).","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"1352_CR181","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","volume":"24","author":"P Kim","year":"2024","unstructured":"Kim, P. et al. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR\u2013Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Lancet Infect. Dis. 24, 1319\u20131332 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1352_CR182","doi-asserted-by":"publisher","first-page":"000192","DOI":"10.23880\/EIJ-16000192","volume":"5","author":"S Turdieva","year":"2021","unstructured":"Turdieva, S. T. & Nasirova, G. R. Bacteriophagic therapy: an alternative to antibacterial therapy in acute tonsillitis. Epidemiol. Int. J. 5, 000192 https:\/\/doi.org\/10.23880\/EIJ-16000192 (2021).","journal-title":"Epidemiol. Int. J."},{"key":"1352_CR183","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/v15020499","volume":"15","author":"E Fedorov","year":"2023","unstructured":"Fedorov, E. et al. Short-term outcomes of phage\u2013antibiotic combination treatment in adult patients with periprosthetic hip joint infection. Viruses 15, 499 https:\/\/doi.org\/10.3390\/v15020499 (2023).","journal-title":"Viruses"},{"key":"1352_CR184","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12968\/jowc.2009.18.6.42801","volume":"18","author":"DD Rhoads","year":"2009","unstructured":"Rhoads, D. D. et al. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J. Wound Care 18, 237\u2013243 (2009).","journal-title":"J. Wound Care"},{"key":"1352_CR185","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaoto.2019.1191","volume":"145","author":"ML Ooi","year":"2019","unstructured":"Ooi, M. L. et al. Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to Staphylococcus aureus. JAMA Otolaryngol. Head Neck Surg. 145, 723\u2013729 (2019).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"1352_CR186","first-page":"262","volume":"3","author":"H Abul-Hassan","year":"1990","unstructured":"Abul-Hassan, H., El-Tahan, A., Massoud, B. & Gomaa, R. Bacteriophage therapy of Pseudomonas burn wound sepsis. Ann. Medit. Burns Club 3, 262\u2013264 (1990).","journal-title":"Ann. Medit. Burns Club"},{"key":"1352_CR187","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","volume":"41","author":"K Markoishvili","year":"2002","unstructured":"Markoishvili, K. et al. A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int. J. Dermatol. 41, 453\u2013458 (2002).","journal-title":"Int. J. Dermatol."},{"key":"1352_CR188","doi-asserted-by":"publisher","DOI":"10.1080\/21597081.2016.1251379","volume":"6","author":"AV Aleshkin","year":"2016","unstructured":"Aleshkin, A. V. et al. Phagebiotics in treatment and prophylaxis of healthcare-associated infections. Bacteriophage 6, e1251379 (2016).","journal-title":"Bacteriophage"},{"key":"1352_CR189","doi-asserted-by":"publisher","first-page":"e1463","DOI":"10.1093\/cid\/ciac694","volume":"76","author":"JB Doub","year":"2023","unstructured":"Doub, J. B. et al. Experience using adjuvant bacteriophage therapy for the treatment of 10 recalcitrant periprosthetic joint infections: a case series. Clin. Infect. Dis. 76, e1463\u2013e1466 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1352_CR190","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/v12050512","volume":"12","author":"A Goulet","year":"2020","unstructured":"Goulet, A., Spinelli, S., Mahony, J. & Cambillau, C. Conserved and diverse traits of adhesion devices from siphoviridae recognizing proteinaceous or saccharidic receptors. Viruses 12, 512 (2020).","journal-title":"Viruses"},{"key":"1352_CR191","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-60327-164-6_13","volume":"501","author":"HW Ackermann","year":"2009","unstructured":"Ackermann, H. W. Phage classification and characterization. Methods Mol. Biol. 501, 127\u2013140 (2009).","journal-title":"Methods Mol. Biol."},{"key":"1352_CR192","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00705-022-05694-2","volume":"168","author":"D Turner","year":"2023","unstructured":"Turner, D. et al. Abolishment of morphology-based taxa and change to binomial species names: 2022 taxonomy update of the ICTV bacterial viruses subcommittee. Arch. Virol. 168, 74 (2023).","journal-title":"Arch. Virol."},{"key":"1352_CR193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003825","volume":"9","author":"LM Bobay","year":"2013","unstructured":"Bobay, L. M., Touchon, M. & Rocha, E. P. Manipulating or superseding host recombination functions: a dilemma that shapes phage evolvability. PLoS Genet. 9, e1003825 (2013).","journal-title":"PLoS Genet."},{"key":"1352_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48686-3","volume":"15","author":"X Ge","year":"2024","unstructured":"Ge, X. & Wang, J. Structural mechanism of bacteriophage lambda tail\u2019s interaction with the bacterial receptor. Nat. Commun. 15, 4185 (2024).","journal-title":"Nat. Commun."},{"key":"1352_CR195","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1073\/pnas.1119719109","volume":"109","author":"C Garcia-Doval","year":"2012","unstructured":"Garcia-Doval, C. & van Raaij, M. J. Structure of the receptor-binding carboxy-terminal domain of bacteriophage T7 tail fibers. Proc. Natl Acad. Sci. USA 109, 9390\u20139395 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1352_CR196","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.molcel.2009.04.009","volume":"34","author":"Y Xiang","year":"2009","unstructured":"Xiang, Y. et al. Crystallographic insights into the autocatalytic assembly mechanism of a bacteriophage tail spike. Mol. Cell 34, 375\u2013386 (2009).","journal-title":"Mol. Cell"},{"key":"1352_CR197","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoint tables. EUCAST https:\/\/www.eucast.org\/clinical_breakpoints (2023)."},{"key":"1352_CR198","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1128\/AAC.44.12.3249-3256.2000","volume":"44","author":"LP Kotra","year":"2000","unstructured":"Kotra, L. P., Haddad, J. & Mobashery, S. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 44, 3249\u20133256 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1352_CR199","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/pro.3737","volume":"29","author":"JF Fisher","year":"2020","unstructured":"Fisher, J. F. & Mobashery, S. Constructing and deconstructing the bacterial cell wall. Protein Sci. 29, 629\u2013646 (2020).","journal-title":"Protein Sci."},{"key":"1352_CR200","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1006\/mthe.2000.0212","volume":"2","author":"P Shabram","year":"2000","unstructured":"Shabram, P. & Aguilar-Cordova, E. Multiplicity of infection\/multiplicity of confusion. Mol. Ther. 2, 420\u2013421 (2000).","journal-title":"Mol. Ther."},{"key":"1352_CR201","doi-asserted-by":"publisher","first-page":"S337","DOI":"10.1093\/cid\/ciad514","volume":"77","author":"O Yerushalmy","year":"2023","unstructured":"Yerushalmy, O. et al. Towards standardization of phage susceptibility testing: the Israeli Phage Therapy Center \u201cclinical phage microbiology\u201d\u2014a pipeline proposal. Clin. Infect. Dis. 77, S337\u2013S351 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1352_CR202","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1099\/mic.0.26822-0","volume":"150","author":"JV Kus","year":"2004","unstructured":"Kus, J. V., Tullis, E., Cvitkovitch, D. G. & Burrows, L. L. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150, 1315\u20131326 (2004).","journal-title":"Microbiology"},{"key":"1352_CR203","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1128\/iai.62.2.596-605.1994","volume":"62","author":"E Mahenthiralingam","year":"1994","unstructured":"Mahenthiralingam, E., Campbell, M. E. & Speert, D. P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62, 596\u2013605 (1994).","journal-title":"Infect. Immun."}],"updated-by":[{"DOI":"10.1038\/s41579-026-01394-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000}}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01352-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:02:36Z","timestamp":1793088156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01352-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":203,"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1038\/s41579-026-01352-5","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"22 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41579-026-01394-9","URL":"https:\/\/doi.org\/10.1038\/s41579-026-01394-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}